IRCT20141209020258N165招募中3 期
Evaluation of the effect of L-Carnitine on patients with moderate to severe condition of Covid-19 ?admitted to critical care unit
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 28 years 至 75 years（—）
- 性别
- All
入选标准
- •Suffering Covid-19 without intubation
- •Apache less than 25
- •28 to 75 years
- •Absence of acute asthma
- •Absence of acute pulmonary hemorrhage
- •Absence of lung tumor
- •Absence of untreated pneumothorax
- •Do not take anticoagulants (coumadin group such as warfarin)
- •No history of kidney or liver disease
- •No diabetes (because of the risk of hypoglycemia)
- •No history of seizures
排除标准
- •Patient dissatisfaction with attending the study for any reason
研究者
相似试验
进行中（未招募）
不适用
Effects of L-carnitine administration in patients with elevated Lp(a)levels. - NDDislipidemic patients with Lp(a)>35 mg/dlLDL-C<190 mg/dl, TG<500 mg/dlMedDRA version: 9.1Level: LLTClassification code 10062060EUCTR2010-022041-19-ITRostaQuo S.p.A.
招募中
2 期
Effect of L Carnitine on severity of uremic restless legs syndromeRestless leg syndrome.Restless legs syndromeG25.81IRCT20130812014333N171Kermanshah University of Medical Sciences82
招募中
3 期
Effect of L-carnitine in Ischemic StrokeIschemic stroke.Cerebral infarctionIRCT20221206056734N1Ahvaz University of Medical Sciences82
已完成
不适用
Evaluation of the effect of L-carnitine administration on peritoneal membrane function in peritoneal dialysis patients.Secondary carnitine deficiencyJPRN-UMIN000031514Division of Nephrology, Department on Medicine, Kurume University60
已完成
不适用
Evaluation of the effect of L-carnitine administration on survival rates in chronic hemodialysis patientsSecondary carnitine deficiencyJPRN-UMIN000034152Division of Nephrology, Department on Medicine, Kurume University2,000